EDMONTON, Alberta (AP) — EDMONTON, Alberta (AP) — Aurinia Pharmaceuticals Inc. (AUPH) on Friday reported third-quarter net income of $31.7 million. On a per-share basis, the Edmonton, Alberta-based company said it had profit of 23 cents. The biotechnology company posted revenue of $83.7 million in the period. Aurinia expects full-year revenue in the range of...